Bunge Global has reported a staggering 56.9% increase in revenue over the past year, totaling $70.33 billion, alongside a net income of $816 million. Despite facing declines in net profit and revenue in recent quarters, the company maintains a strong market presence and a capitalization of $23.9 billion. With current stock trading at $122.45 and a share repurchase plan of $3 billion, analysts forecast an 8.4% potential increase in value, showcasing Bunge's resilience in a shifting market landscape.
“Bunge Global · has one-year revenue growth · Bunge Global · +56.9%”
“Bunge Global · is a company in · Consumer Staples”
“Bunge · is a company in · Global”
“Bunge Global · is connected to · healthcare companies · Abbott Laboratories, AbbVie, Agilent Technologies”
“Bunge Global · is connected to · financial companies · Aflac, Allstate, American Express”
“Bunge Global · is a part of · companies listed”
“ADM · approached Bunge Ltd. about a takeover · takeover · January 2018”
“ADM · approached · Bunge Ltd. about a takeover · January 2018”
“Bunge · had a market value · about $9.8 billion · January 2018”
“Bunge Global · is a member of · S&P 500 · true”
“Bunge Global · is a company related to · Food · Health Care”
“Gregory A. Heckman · is CEO of · Bunge Global”
